Despite pervasive consumer disapproval, scientists and seed companies have far from abandoned GMOs as a subject of research and development and some new approaches using GM technology could address the more pervasive consumer concerns.
iBio uses highly automated indoor farming methods to manufacture pharmaceutical drugs and, according to Barry Holtz, president, it already has much of the technology that today’s food-growing indoor farms are just starting to develop.
Bayer, through Condon, has indicated that it is aware the merger presents an opportunity to reset public opinion about controversial technologies like GMOs and Dicamba, but the executive announcement last week suggests a complete overhaul is not in the cards.
Chipotle loses a controversial executive, cultured leather comes to New York, TechAccel commits to innovation at UC Davis, and more in this week's brief.
Plastomics is working to shorten the pipeline for developing new seeds with multiple transgenic traits, increasing the speed and lowering the cost of designing new seeds using chloroplast engineering.
“I think CRISPR and other gene editing tools mark a real turning point in the conversation,” Sam Kass, partner at Acre Venture Partners and former senior policy advisor for nutrition in the White House, told the audience of the Food Loves Tech.
US Secretary of Agriculture Sonny Perdue announced plans to withdraw Obama-era revisions to biotechnology regulations involving genetic modification and editing plus more in our weekly industry brief.
Controversial Monsanto email communications have been revealed by the New York Times.
Calyxt spun out from its parent company Cellectis to price an oversubscribed IPO at the bottom of the price range, while analysts remain concerned about gene editing regulation.
Trump's nomination of Sam Clovis, a new hire at Finistere Ventures, Hampton Creek's board fallout, and Arlon's Brazilian dairy investment are also covered this week.
The US agriculture industry has responded to requests for comments about a relaxation in the regulation of genetically engineered (GE) organisms.
Roslin Technologies has spun out of the University of Edinburgh and The Royal (Dick) School of Veterinary Studies, to raise £10 million ($12.4m) in funding to commercialize its first products.
Gene editing was a key topic discussed at this week’s World Agri-Tech Innovation Summit in San Francisco.
Equity investing in just one way TechAccel, a venture development organization, works to accelerate innovation in agriculture.
We are very proud of the coverage we've given the food and agriculture technology market over the year, but there are always, of course, stories in other publications that we wish we'd written!
It was a busy week for the agriculture sector including anti-Trump CEOs, cannabis legalization, organic farmland increases and GMO bans.
The idea for this week's podcast came from Sanjeev Krishnan, founding partner at S2G Ventures, the Chicago-based food and agtech venture capital firm.
This is Temasek's 3rd agtech investment in a year.
CRISPR has been lauded as the cheapest, fastest, and most precise gene-editing tool on the market, and it's not subjected to the tainted GMO label, but for how much longer?
The gene-editing powerhouse the merger between Bayer and Monsanto could produce has been less discussed in media and investment circles, but is a major part of the transaction, writes Emma Cowan.